Home » Newsletters » BioWorld

BioWorld

March 11, 1992

View Archived Issues

IMMU TO TARGET AIDS-RELATED LYMPHOMA

COCENSYS STARTS TRIALS OF SLEEP INDUCER

NEMATODES ATTRACT $31.2M FOR BIOSYS

GEL CUTS SHEDDING OF HERPES VIRUS

GENZYME GAINS PHOSPHOLIPID PRODUCT

TWO BIOTECH IPOS RANK IN TOP 10

NIH RELEASES DNA PATENT APPLICATION

SECOND APPROVAL FOR EUROCETUS DRUG

AGOURON DESIGNS SYNTHETIC TUMOR COMPOUND

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.